Skip to content

Use of Plasma or Serum SMOC2 as a Diagnostic Marker of Fibrosis and NASH

Patients can be screened by SMOC2 levels in plasma/serum to identify those for which a biopsy is relevant, and high risk patients

Published: 31st August 2022
Use of Plasma or Serum SMOC2 as a Diagnostic Marker of Fibrosis and NASH
Crystal light, https://stock.adobe.com/uk/525564337, stock.adobe.com
Patents
  • Priority IP application in 2022
Seeking
  • Development partner
  • Commercial partner